Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma.

MLA

Li ZM, et al. “Serum Beta2-Microglobin Is a Predictor of Prognosis in Patients with Upper Aerodigestive Tract NK/T-Cell Lymphoma.” Annals of Hematology, vol. 91, no. 8, Aug. 2012, pp. 1265–70. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=104444343&authtype=sso&custid=ns315887.

APA

Li ZM, Zhu YJ, Sun J, Xia Y, Huang JJ, Zou BY, Lin TY, Huang HQ, & Jiang WQ. (2012). Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma. Annals of Hematology, 91(8), 1265–1270.

Chicago

Li ZM, Zhu YJ, Sun J, Xia Y, Huang JJ, Zou BY, Lin TY, Huang HQ, and Jiang WQ. 2012. “Serum Beta2-Microglobin Is a Predictor of Prognosis in Patients with Upper Aerodigestive Tract NK/T-Cell Lymphoma.” Annals of Hematology 91 (8): 1265–70. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=104444343&authtype=sso&custid=ns315887.